Epilepsy is a chronic brain disorder characterized by sudden and recurrent episodes of seizure.
It is one of the most common neurological disorders worldwide, affecting people of all ages.

Market Analysis and Insights: Global Epilepsy Drug Market
The global Epilepsy Drug market is valued at US$ 1839.1 million in 2019. The market size will reach US$ 2031.8 million by the end of 2026, growing at a CAGR of 1.4% during 2021-2026.

Global Epilepsy Drug Scope and Market Size
Epilepsy Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Epilepsy Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
First Generation Drugs
Second Generation Drugs
Third Generation Drugs

Segment by Application
Hospital
Research

By Company
Pfizer
Eisai
Novartis
Sanofi
Union Chimique Belge
Abbott
GlaxoSmithKline
Sunovion Pharmaceuticals
Teva Pharmaceutical

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia